Cerebral Fungal Infection in Pediatric Cancer Patients

被引：5
作者：
Haßler A. [1 ]
Porto L. [2 ]
Lehrnbecher T. [1 ]
机构：
[1] Pediatric Hematology and Oncology, Hospital for Children and Adolescents, Theodor-Stern-Kai 7, Frankfurt
[2] Neuroradiology Department, Johann Wolfgang Goethe-University, Frankfurt
来源：
Current Fungal Infection Reports | 2015年 / 9卷 / 1期
关键词：
Cancer; Central nervous system; Child; Hematopoietic stem cell transplantation; Invasive fungal infection;
D O I：
10.1007/s12281-014-0213-y
中图分类号：
学科分类号：
摘要：
Invasive fungal disease (IFD) significantly contributes to morbidity and mortality in pediatric cancer patients, especially in those with acute leukemia and allogeneic hematopoietic stem cell transplantation. Cerebral fungal infections are a particular severe form of IFD, as they are difficult to diagnose and require aggressive treatment, and cure rates are still unacceptably low. Here, we review the current data on epidemiology, diagnosis, and the management of cerebral fungal infection in pediatric cancer patients and outline important questions which have to be addressed by further research. © 2015, Springer Science+Business Media New York.
引用
收藏
页码：6 / 14
页数：8
相关论文
共 85 条
  • [1] Nieves D.J., Antonio C., Recent studies on invasive fungal diseases in children and adolescents: an update, Curr Fungal Infect Rep, 8, pp. 56-66, (2014)
  • [2] Benjamin D.K., Miller W.C., Bayliff S., Et al., Infections diagnosed in the first year after pediatric stem cell transplantation, Pediatr Infect Dis J, 21, pp. 227-234, (2002)
  • [3] Castagnola E., Rossi M.R., Cesaro S., Et al., Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study, Pediatr Blood Cancer, 55, pp. 1103-1107, (2010)
  • [4] Groll A.H., Kurz M., Schneider W., Et al., Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival, Mycoses, 42, pp. 431-442, (1999)
  • [5] Hale K.A., Shaw P.J., Dalla-Pozza L., Et al., Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant, Br J Haematol, 149, pp. 263-272, (2010)
  • [6] Hovi L., Saarinen-Pihkala U.M., Vettenranta K., Et al., Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years, Bone Marrow Transplant, 26, pp. 999-1004, (2000)
  • [7] Kaya Z., Gursel T., Kocak U., Et al., Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis, Pediatr Blood Cancer, 52, pp. 470-475, (2009)
  • [8] Kobayashi R., Kaneda M., Sato T., Et al., The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan, J Pediatr Hematol Oncol, 30, pp. 886-890, (2008)
  • [9] Lin S.J., Schranz J., Teutsch S.M., Aspergillosis case-fatality rate: systematic review of the literature, Clin Infect Dis, 32, pp. 358-366, (2001)
  • [10] Mor M., Gilad G., Kornreich L., Et al., Invasive fungal infections in pediatric oncology, Pediatr Blood Cancer, 56, pp. 1092-1097, (2011)
123456789